Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.86
- Piotroski Score 6.00
- Grade Hold
- Symbol (MDT)
- Company Medtronic plc
- Price $88.12
- Changes Percentage (-2.21%)
- Change -$2
- Day Low $87.70
- Day High $89.50
- Year High $92.68
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
- Last Earnings 08/15/2024
- Ex-Dividend for 5/16 Dividend 09/27/2024
- Dividend Payable 10/11/2024
- Today N/A
- Next Earnings (Estimated) 11/19/2024
- Fiscal Year End N/A
- Average Stock Price Target $104.00
- High Stock Price Target $165.00
- Low Stock Price Target $80.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.76
- Trailing P/E Ratio 30.46
- Forward P/E Ratio 30.46
- P/E Growth 30.46
- Net Income $3.68 B
Income Statement
Quarterly
Annual
Latest News of MDT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
International Revenue Growth Makes Medtronic (MDT) An Attractive Investment For Conservative Investors
Medtronic PLC investors have been pleased with dividends. The company, a global medical technology leader, offers a range of medical devices for various health conditions. Recent growth in internation...
By Yahoo! Finance | 2 weeks ago -
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)?
Medtronic plc's stock has grown 16% on the NYSE recently, reaching a yearly high. Despite analysts' extensive coverage, the stock is still undervalued, presenting a potential buying opportunity....
By Yahoo! Finance | 3 weeks ago -
Medtronic plc (NYSE:MDT) Shares Could Be 33% Below Their Intrinsic Value Estimate
The analyst price target for Medtronic (MDT) is 29% lower than their estimated fair value. Using the Discounted Cash Flow (DCF) model, the intrinsic value is calculated at US$171 billion, indicating t...
By Yahoo! Finance | 1 month ago
